Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

Cancer Cell - United States
doi 10.1016/j.ccell.2018.09.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF

Cancer Research
Cancer ResearchOncology
2018English

Induction of the Apoptosis Inhibitor ARC by Ras in Human Cancers

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Autoinhibition in Ras Effectors Raf, PI3Kα, and RASSF5: A Comprehensive Review Underscoring the Challenges in Pharmacological Intervention

Biophysical Reviews
Molecular BiologyStructural BiologyBiophysics
2018English

REDD1 Loss Reprograms Lipid Metabolism to Drive Progression of RAS Mutant Tumors

Genes and Development
GeneticsDevelopmental Biology
2020English

FOXD3 Is a Mutant B-Raf-Regulated Inhibitor of G1-S Progression in Melanoma Cells

Cancer Research
Cancer ResearchOncology
2010English

Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras With the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

TSC1 Loss Synergizes With KRAS Activation in Lung Cancer Development in the Mouse and Confers Rapamycin Sensitivity

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy